Avecho Biotechnology (ASX:AVE) passes “crucial” two-year stability milestone for CBD capsule
Avecho Biotechnology (AVE) has passed a “crucial” two-year stability milestone for its…
Avecho Biotechnology Limited (ASX:AVE)
About Avecho Biotechnology Limited
Key Information
AVE In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 26/03/2024 | Price Sensitive PS Avecho commences Phase III insomnia trial | 202.98KB | 4.2K |
| 18/03/2024 | Avecho to present at NWR Virtual Healthcare Conference | 87.99KB | 8.5K |
| 14/03/2024 | Price Sensitive PS Avecho meets TGA ahead of Phase III Clinical Trial | 67.34KB | 370 |
| 07/03/2024 | Price Sensitive PS AVE receives final ethics approval for Phase III CBD trial | 74.51KB | 696 |
| 29/02/2024 | Appendix 4G and Corporate Governance Statement | 574KB | 295 |
| 29/02/2024 | Price Sensitive PS Appendix 4E and Annual Report 31 December 2023 | 1.4MB | 261 |
| 31/01/2024 | Price Sensitive PS December 2023 Quarterly Activities Report & Appendix 4C | 299.59KB | 2.3K |
| 28/11/2023 | Expiry of Quoted Options | 241.34KB | 310 |